According to Liu, his preferred option is faricimab, a fairly new agent that was FDA-approved for wet AMD in 2022. The drug ...

Prescription Drug User Fee Act (PDUFA) goal date of December 31, 2025 ISELIN, N.J., (GLOBE NEWSWIRE) -- Outlook Therapeutics, ...

ISELIN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the treatment of ...

Prescription Drug User Fee Act (PDUFA) goal date of December 31, 2025 ISELIN, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on ...

OCT has transformed retinal practice, enhancing diagnostic accuracy and treatment efficiency while reducing reliance on ...

A single intravitreal injection of 4D-150 helped patients with wet age-related macular degeneration maintain visual acuity ...

EyePoint Pharmaceuticals' DURAVYU trials for wet AMD receive positive DSMC review, highlighting safety and potential for ...

The FDA also approved an every 4 week dosing regimen across all approved indications for patients who may not maintain a response on extended dosing intervals following successful initial treatment.

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

An electrocardiogram (ECG) monitoring the heart of a Tennessee inmate executed by lethal injection in August reportedly showed "sustained cardiac activity" for nearly two minutes after Byron Black was ...

Washington - The US state of Tennessee has executed Steve Henley, 55, who was convicted of killing an older couple, a crime he denied until his death, officials said Wednesday. Henley was executed by ...